Hospital
Northern Dutchess Hospital
Northern Dutchess Hospital was paid $11.21M by Medicaid between Oct 2018 and Dec 2024, across 141 billing codes. Its largest line is 99283, emergency room visit (moderate) — 14% of everything it billed.
33Billing provider infoNORTHERN DUTCHESS HOSPITAL
RHINEBECK, NY 12572
RHINEBECK, NY 12572
33aNPI1124072715assigned 05/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.21M
24GClaims167,873
24DCodes billed141
24AFirst – last monthOct 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#77 of 231
Median peer was paid$561K
This provider vs. median20×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13 | $1K | |
| 2019 | 8,769 | $507K | |
| 2020 | 21,405 | $1.29M | |
| 2021 | 30,172 | $2.06M | |
| 2022 | 37,191 | $2.44M | |
| 2023 | 41,947 | $2.81M | |
| 2024incomplete | 28,376 | $2.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 9,226 | 8,863 | $1.60M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 9,126 | 8,680 | $1.48M |
| 96361 | Intravenous infusion, hydration; each additional hour | 11% | 4,363 | 3,898 | $1.27M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.3% | 4,362 | 4,153 | $710K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 5.8% | 1,942 | 1,905 | $646K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.5% | 2,241 | 2,197 | $616K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.2% | 5,650 | 1,858 | $579K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4.5% | 2,347 | 1,788 | $499K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.8% | 1,507 | 1,480 | $429K |
| 80053 | Comprehensive metabolic panel | 3.1% | 13,177 | 11,598 | $344K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.1% | 2,149 | 2,096 | $342K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.9% | 1,396 | 1,335 | $328K |
129 more codes
| G0378 | Hospital observation service, per hour | 2.7% | 405 | $303K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.0% | 3,259 | $224K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 4,625 | $223K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.8% | 317 | $197K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.5% | 554 | $167K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.3% | 251 | $144K |
| 59025 | Fetal non-stress test | <1% | 391 | $109K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 134 | $108K |
| 97161 | <1% | 517 | $72K | |
| 93017 | <1% | 374 | $66K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 981 | $58K |
| 86850 | <1% | 1,189 | $52K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 664 | $50K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 680 | $45K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,216 | $42K |
| 93975 | <1% | 86 | $41K | |
| 86901 | <1% | 1,191 | $34K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 531 | $30K |
| 86900 | <1% | 1,188 | $25K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,676 | $23K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 122 | $23K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 72 | $21K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 90 | $21K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,938 | $20K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 311 | $18K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,685 | $17K |
| 81025 | <1% | 4,654 | $15K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 14 | $15K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 615 | $15K |
| 76830 | Ultrasound, transvaginal | <1% | 406 | $14K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 13 | $14K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 62 | $12K |
| 83880 | <1% | 363 | $12K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,679 | $10K |
| 85610 | <1% | 2,345 | $10K | |
| 76801 | <1% | 82 | $9K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 203 | $9K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 143 | $9K |
| 12001 | <1% | 14 | $8K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,596 | $7K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 33 | $5K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 679 | $5K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 116 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,016 | $4K |
| 96367 | <1% | 25 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,061 | $4K |
| 93971 | <1% | 40 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 130 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,375 | $3K |
| 93225 | <1% | 12 | $3K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 12 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,663 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 16 | $3K |
| 76641 | <1% | 118 | $3K | |
| 88304 | <1% | 49 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,483 | $1K |
| 99406 | <1% | 73 | $1K | |
| 77065 | Tomosynthesis, mammo | <1% | 15 | $1K |
| 93226 | <1% | 12 | $1K | |
| 97165 | <1% | 13 | $1K | |
| 81001 | <1% | 3,332 | $869.60 | |
| 90715 | <1% | 28 | $848.61 | |
| 87484 | <1% | 43 | $840.72 | |
| 87468 | <1% | 43 | $840.71 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 13 | $809.49 |
| 83735 | <1% | 2,096 | $718.90 | |
| 85027 | <1% | 460 | $690.76 | |
| 84484 | <1% | 2,509 | $622.59 | |
| 96417 | <1% | 21 | $580.56 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,068 | $531.22 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $522.44 |
| 87400 | <1% | 2,598 | $510.90 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,844 | $467.84 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,356 | $453.59 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 209 | $441.30 |
| 83605 | <1% | 937 | $414.63 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 69 | $399.00 |
| 82947 | <1% | 475 | $387.68 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $358.40 |
| 83690 | <1% | 2,435 | $334.93 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $274.46 |
| 85730 | <1% | 535 | $200.14 | |
| 81003 | <1% | 2,159 | $195.69 | |
| 86618 | <1% | 573 | $170.62 | |
| 85379 | <1% | 519 | $147.35 | |
| 87420 | <1% | 707 | $133.64 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,965 | $118.60 |
| 87081 | <1% | 435 | $104.04 | |
| 87040 | <1% | 190 | $96.74 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 436 | $94.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,194 | $79.64 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 535 | $78.58 |
| 82565 | <1% | 193 | $78.23 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 563 | $70.56 |
| 87077 | <1% | 319 | $59.04 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,041 | $55.79 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,961 | $43.35 |
| 84702 | <1% | 43 | $40.47 | |
| 82948 | <1% | 325 | $38.23 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 28 | $36.81 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 131 | $34.76 |
| 73030 | <1% | 13 | $29.70 | |
| 87186 | <1% | 86 | $24.48 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 67 | $21.89 |
| 73630 | <1% | 14 | $20.84 | |
| 87207 | <1% | 128 | $16.83 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12 | $14.82 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 17 | $10.80 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 373 | $9.82 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,216 | $8.46 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,091 | $7.74 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 168 | $6.35 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 207 | $5.70 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 14 | $2.40 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,130 | $1.50 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 49 | $0.49 |
| 96376 | 0% | 299 | $0.00 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 162 | $0.00 |
| 95806 | 0% | 24 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 128 | $0.00 |
| 85651 | 0% | 41 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 28 | $0.00 |
| 82150 | 0% | 13 | $0.00 | |
| 84703 | 0% | 14 | $0.00 | |
| 87205 | 0% | 12 | $0.00 | |
| 87070 | 0% | 12 | $0.00 | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 0% | 16 | $0.00 |
| A4649 | Surgical supply; miscellaneous | 0% | 38 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROSENBERG, STEVEN (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Norwalk Hospital Association | Norwalk, CT | $39K |
| Steven H Rosenberg MD INC | Torrance, CA | $25K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.